Government & Policy
Payers will not only need to comply with the 2024 CMS Final Rule pertaining to materials and content, but they will need to go the extra mile because it affects star ratings, says Ernie Crawford, president and CEO of Crawford Technologies.
The Coalition of Health AI brings together more than 1,300 organizations, including government and industry leaders, to build consensus-driven best practices and standards for using AI in healthcare, explains Dr. Brian Anderson, CEO of CHAI.
Over time interoperability standards have had a broadening effect on the healthcare technology industry, and the pace of improvements has increased, to the benefit of patients, says Michael Nusbaum, president of MH Nusbaum & Associates.
Among the top global policy issues at HIMSS24: AI regulation, patient access and equity. Tom Leary, SVP and head of government relations at HIMSS, explains how the organization advocates for health policies that support those goals.
J29's origin, its work interpreting healthcare policies for public agencies, and its mission of contributing to nonprofits, including the "HIMSS Gives Back" program, presented by Tracy Mills, CEO and founder, and Nick Vass, president.
AI policies, patient experience, the next generation of CIOs, nursing informatics and more: Healthcare IT insiders and thought leaders discuss issues affecting the industry.
Governments need to develop and fund enterprise architecture to solve major health issues like homelessness, according to Gabriel Seidman, director of policy at Ellison Institute of Technology, and his colleagues.
With 80% of nationwide prescribers utilizing e-prescribing in their practice, some US states are beginning to require the same level of e-prescribing compliance for non-controlled prescriptions to further mitigate the risk of errors and potential penalties.
Reflecting on recent interoperability milestones, reasonable AI transparency and electronic case-reporting timelines, and TEFCA's FAST track to FHIR exchange, Micky Tripathi, ONC national coordinator, is candid about the year ahead.
Amazon Web Services has concerns around AI use in healthcare and regulating the technology. But it can show the benefits of AI/ML in helping life sciences firms with drug development. Dr. Jared Saul, chief medical officer at AWS, discusses the issues.